Huntington’s Advocates Press FDA to Approve UniQure’s Treatment
Clinical trial showed it slowed progression by 75% over three years.
This article is for subscribers only.
Hi, it’s Gerry in New York, where I’ve been thinking about how much power patient groups have at the FDA. More on that in a moment, but first ...
How much influence do patient advocates have with the Trump administration?